 REDWOOD CITY, Calif., April 06, 2021 GLOBE NEWSWIRE -- Atreca, Inc. Atreca NASDAQ: BCEL, a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that it will participate in the following upcoming virtual investor conferences: 